title: Peripheral blood T cell subsets as prognostic indicators of chemotherapy outcome in AIDS patients with large cell lymphoma.
authors: Department of Medicine, University of Miami, School of Medicine, E.M. Papper Laboratory of Clinical Immunology, Florida 33101, USA.
authors: R
authors: R
authors: Patarca
authors: A
authors: A
authors: Freidlander
authors: W J
authors: WJ
authors: Harrington
authors: L
authors: L
authors: Cabral
authors: J J
authors: JJ
authors: Byrnes
authors: M A
authors: MA
authors: Fletcher
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D015703:Antigens, CD / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003520:Cyclophosphamide / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D015703:Antigens, CD; D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016049:Didanosine; D011241:Prednisone